Next Financial Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Next Financial Group’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$68K	Buy	1,561 +489	+46%	+$23.1K	﹤0.01%	1333
2021 Q3	$54K	Hold	1,072	–	–	﹤0.01%	1380
2021 Q2	$56K	Hold	1,072	–	–	﹤0.01%	1344
2021 Q1	$49K	Buy	1,072 +682	+175%	+$33.3K	﹤0.01%	1288
2020 Q4	$18K	Sell	390 -60	-13%	-$2.59K	﹤0.01%	1577
2020 Q3	$18K	Buy	+450	New	+$17.3K	﹤0.01%	1448

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Next Financial Group's IDNA Position: Q4 2021 in Review

Next Financial Group increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 46% in Q4 2021, buying an estimated $23.1K and bringing the position to 1,561 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Next Financial Group first reported a position in IDNA in Q3 2020 and has held it in 6 quarters since. 103 funds tracked by Wall St. Rank hold IDNA as of Q4 2021.

Next Financial Group held 1,561 shares of iShares Genomics Immunology and Healthcare ETF worth $68K as of Q4 2021.
Next Financial Group bought 489 iShares Genomics Immunology and Healthcare ETF shares in Q4 2021, an estimated $23.1K.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1333 holding.
Next Financial Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and has held it in 6 quarters since.
103 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.